End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3 NZD | -4.15% | -2.91% | -14.29% |
01/05 | AFT Pharmaceuticals Signs Brazil Licensing Agreement for Maxigesic IV | MT |
24/04 | New Zealand Shares Rise on US Earnings Rally; AFT Pharmaceuticals to Develop Topical Scar Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.29% | 187M | |
+33.25% | 699B | |
+24.50% | 571B | |
-3.55% | 364B | |
+18.16% | 326B | |
+4.36% | 286B | |
+14.59% | 236B | |
+4.77% | 198B | |
-10.35% | 194B | |
-3.69% | 149B |
- Stock Market
- Equities
- AFT Stock
- News AFT Pharmaceuticals Limited
- Aft Pharmaceuticals : Posts Decline in Profit, Rise in Revenue for Six Months Ended September; Shares Down 5%